Softgel Manufacturing Machine Market Size, Share, Growth, and Industry Analysis, By Types (Below 3RPM, 3-5 RPM, 5-7 RPM, 7-9 RPM, Others) , Applications (Pharmaceutical, Health Supplements) and Regional Insights and Forecast to 2035

Softgel Manufacturing Machine Market Size

The Global Softgel Manufacturing Machine market size was valued at USD 291.74 Million in 2025, is projected to reach USD 321.50 Million in 2026, and is expected to hit approximately USD 354.29 Million by 2027, surging further to USD 770.56 Million by 2035. This remarkable expansion reflects a robust compound annual growth rate CAGR of 10.2% throughout the forecast period 2026-2035. Rising pharmaceutical production, expanding nutraceutical consumption, increasing contract manufacturing activity, and growing demand for efficient softgel encapsulation are accelerating investment in automated and high-throughput machinery.

In the United States Softgel Manufacturing Machine Market region, pharmaceutical manufacturers, nutraceutical producers, contract manufacturing organizations, and dietary-supplement companies are driving demand for advanced encapsulation equipment. Approximately 75% of large U.S. softgel production facilities use automated systems, while around 62% of supplement manufacturers rely on softgel dosage formats for selected products. More than 90% of equipment purchasing decisions in regulated pharmaceutical environments are influenced by compliance, validation, documentation, cleaning, and process-control requirements.

Key Findings

• Market Size - Valued at USD 321.50 Million in 2026 and expected to reach USD 770.56 Million by 2035, growing at a CAGR of 10.2%.
• Growth Drivers - 54% pharmaceutical demand, 34% nutraceutical demand, 61% automation adoption, and 42% contract-manufacturing purchases support equipment expansion.
• Trends - 61% fully automated installations, 46% high-speed equipment, 48% integrated drying adoption, and 47% monitoring interest define technology trends.
• Key Players - Changsung, SKY SOFTGEL & PACK, Technophar, Pharmagel, GIC Engineering
• Regional Insights - Asia-Pacific holds 38% market share, North America 34%, Europe 22%, and Middle East & Africa 6%, representing 100% globally.
• Challenges - 46% high-speed demand, 33% formulation variability, 29% ribbon-control concerns, and increasing validation requirements challenge consistent production.
• Industry Impact - 61% automation, 54% pharmaceutical demand, 34% nutraceutical demand, and 42% contract manufacturing strengthen equipment modernization.
• Recent Developments - 61% automated installations, 47% monitoring interest, 48% integrated drying adoption, and expanding high-speed systems shape recent equipment innovation.

The Softgel Manufacturing Machine market consists of specialized equipment used to form, fill, seal, and process soft gelatin capsules containing pharmaceutical, nutraceutical, and other liquid or semisolid formulations. Modern machines combine die-roll encapsulation, gelatin-ribbon preparation, precision filling, cooling, sealing, and automated thickness management. Approximately 61% of new softgel equipment installations are fully automated, while high-speed systems exceeding 150,000 softgels per hour represent about 46% of equipment demand in broader manufacturing-equipment assessments. Pharmaceutical applications account for approximately 54% of demand, making drug manufacturing the leading end-use segment.

Softgel Manufacturing Machine Market Trends

The Softgel Manufacturing Machine market is undergoing a substantial transformation as pharmaceutical and nutraceutical manufacturers prioritize automation, higher production efficiency, precision dosing, flexible capsule formats, and improved process monitoring. Approximately 61% of new softgel manufacturing equipment installations are fully automated, compared with approximately 27% for semi-automatic systems and 12% for manual or low-automation configurations. This transition reflects manufacturers' focus on reducing manual intervention, improving batch consistency, and maintaining repeatable production parameters.

High-speed encapsulation is another important trend shaping the Softgel Manufacturing Machine market. Approximately 46% of softgel manufacturing equipment demand is associated with high-speed systems capable of producing more than 150,000 softgels per hour, while approximately 39% falls within medium-speed capacity ranges. Modern equipment increasingly incorporates servo-driven die rolls, automated injection timing, automatic filling-weight adjustment, and recipe storage. Changsung's servo systems demonstrate this direction, with machines such as the 880R operating at approximately 6 RPM and incorporating servo-driven processes and automatic gelatin-thickness control.

Precision dosing and automated quality control are also becoming standard purchasing considerations. Approximately 54% of overall softgel manufacturing equipment demand is connected with pharmaceutical production, where fill-weight consistency, formulation integrity, cleaning validation, and traceability are particularly important. Advanced machines increasingly use automated filling controls, touchscreen interfaces, digital recipes, load-cell monitoring, and automatic gelatin-ribbon thickness systems. Some high-speed machines report filling accuracy approaching 99.5% under specified production conditions, demonstrating the industry's emphasis on tighter dosing control and reduced product variation.

Softgel Manufacturing Machine Market Dynamics

The Softgel Manufacturing Machine market dynamics are shaped by pharmaceutical manufacturing expansion, nutraceutical consumption, contract manufacturing, technological modernization, regulatory requirements, and demand for high-throughput production. Pharmaceutical applications remain the dominant end-use category, while health supplements represent an important growth engine. Approximately 54% of broader softgel manufacturing equipment demand comes from pharmaceutical applications, while around 34% is attributed to nutraceutical and dietary-supplement production. Fully automated systems account for approximately 61% of new installations, reinforcing the shift toward automated process control.

Machine speed is another critical market dynamic. Below 3 RPM machines are generally suited to smaller-scale, development, specialty, or lower-output applications, whereas 3-5 RPM and 5-7 RPM equipment supports progressively higher production requirements. Systems operating around 7-9 RPM represent the premium high-throughput category and require sophisticated die-roll control, filling synchronization, cooling, gelatin-ribbon management, and process monitoring. Manufacturers are increasingly balancing speed with capsule quality because higher rotational speed alone does not guarantee higher usable output.

OPPORTUNITY

Expansion of Nutraceutical and Contract Manufacturing Production

Approximately 34% of broader softgel manufacturing equipment demand comes from nutraceutical applications, while contract manufacturers account for about 42% of equipment purchases. The expansion of dietary supplements, vitamins, omega-based formulations, botanical products, and specialty nutraceuticals is creating opportunities for flexible softgel machines. Manufacturers increasingly require equipment capable of rapid changeovers, multiple capsule sizes, automated recipes, and integrated drying and inspection.

DRIVERS

Rising Demand for Pharmaceutical and Softgel Dosage Manufacturing

Pharmaceutical applications account for approximately 54% of broader softgel equipment demand, making drug manufacturing the primary market driver. Around 61% of new installations are fully automated, reflecting demand for precision dosing, improved productivity, consistent capsule quality, automated monitoring, and lower manual intervention. Rising production of lipid-based formulations, vitamins, supplements, and specialized oral dosage products is strengthening demand for modern encapsulation machinery.

Market Restraints

High Capital Requirements and Complex Equipment Qualification

High initial investment, installation complexity, validation requirements, operator training, and maintenance requirements remain important restraints for the Softgel Manufacturing Machine market. Approximately 38% of manufacturers identify equipment acquisition and installation expenditure as a major purchasing consideration, particularly for smaller pharmaceutical and nutraceutical producers. Around 34% of users highlight maintenance and cleaning complexity, while nearly 31% emphasize the cost and time associated with process qualification. GMP-oriented production requires controlled materials, documented procedures, validated processes, and reliable equipment performance.

Market Challenges

Maintaining High-Speed Production With Consistent Capsule Quality

The major challenge in the Softgel Manufacturing Machine market is maintaining high throughput without compromising fill accuracy, shell thickness, sealing quality, capsule appearance, and product integrity. Approximately 46% of broader equipment demand is associated with high-speed systems, creating strong pressure on manufacturers to improve output while preserving quality. Around 33% of production facilities identify formulation variability as an important operational issue, while approximately 29% face challenges associated with gelatin-ribbon thickness and temperature control. High-speed operation also increases the importance of precise synchronization between die rolls, filling pumps, injection timing, cooling systems, and drying processes. Different formulations can behave differently during encapsulation, requiring adjustments to viscosity, temperature, fill volume, ribbon characteristics, and machine speed.

Segmentation Analysis

The Softgel Manufacturing Machine market is segmented by rotational speed and application, enabling manufacturers to select equipment according to production scale, formulation characteristics, required throughput, and operational complexity. By type, the market includes Below 3 RPM, 3-5 RPM, 5-7 RPM, 7-9 RPM, and Others. Below 3 RPM machines are commonly associated with R&D, specialty products, smaller production batches, and applications requiring controlled encapsulation. The 3-5 RPM segment serves mainstream production environments and balances throughput with process control. Machines operating at 5-7 RPM provide higher production capacity and are increasingly used by commercial pharmaceutical and nutraceutical manufacturers. The 7-9 RPM category represents high-speed equipment designed for large-scale production and requires advanced synchronization and process-control technology.

By Type

Below 3 RPM

Below 3 RPM machines account for approximately 20% of the Softgel Manufacturing Machine market. They are suited to R&D facilities, smaller production batches, specialty formulations, and manufacturers prioritizing controlled encapsulation over maximum throughput. Approximately 44% of lower-speed equipment users prioritize flexibility and formulation development, while around 38% emphasize simple cleaning and tooling changes.

3-5 RPM

The 3-5 RPM category represents approximately 27% of the Softgel Manufacturing Machine market and provides a balance between production speed, filling precision, and operating flexibility. Approximately 58% of mainstream commercial manufacturers prefer this range for standard pharmaceutical and nutraceutical production, particularly where frequent formulation or tooling changes are required.

5-7 RPM

5-7 RPM machines account for approximately 28% of the Softgel Manufacturing Machine market and represent a major commercial production category. Approximately 62% of high-volume pharmaceutical and nutraceutical users prioritize this speed range because it offers higher throughput while maintaining controllable filling, ribbon formation, and sealing processes.

7-9 RPM

The 7-9 RPM category represents approximately 16% of the Softgel Manufacturing Machine market and is positioned toward high-output production. Approximately 57% of users in this category prioritize throughput, while around 49% emphasize automated synchronization, fill-weight control, and process monitoring. These machines require advanced engineering to maintain product consistency at high operating speeds.

Others

Other speed categories account for approximately 9% of the market and include specialized machines designed for unusual formulations, R&D requirements, customized tooling, and application-specific production. Approximately 51% of users in this category prioritize customization, while 43% emphasize flexible tooling and automated process adjustment.

By Application

Pharmaceutical

The Pharmaceutical application represents approximately 66% of the Softgel Manufacturing Machine market and remains the leading demand segment. Approximately 72% of pharmaceutical manufacturers using softgel technology prioritize automated encapsulation, while around 63% emphasize fill-weight consistency, validation, traceability, and cleaning. Softgel dosage forms are particularly relevant for lipid-based formulations and compounds requiring enhanced bioavailability.

Health Supplements

Health Supplements account for approximately 34% of the Softgel Manufacturing Machine market and represent a major source of equipment demand. Approximately 62% of supplement manufacturers prioritize softgel formats for oils, vitamins, botanical extracts, and nutraceutical formulations. Around 55% increasingly seek automated systems capable of rapid changeovers and flexible capsule formats.

Softgel Manufacturing Machine Market Regional Outlook

The Softgel Manufacturing Machine market is geographically diversified across North America, Europe, Asia-Pacific, and Middle East & Africa, with demand closely linked to pharmaceutical production, nutraceutical manufacturing, contract manufacturing, and equipment modernization. Asia-Pacific accounts for approximately 38% of regional demand, followed by North America at 34%, Europe at 22%, and Middle East & Africa at 6%. 

North America

North America holds approximately 34% of the Softgel Manufacturing Machine market, supported by pharmaceutical manufacturing, nutraceutical production, contract manufacturing, and stringent equipment qualification requirements. The United States accounts for approximately 82% of regional demand, while Canada contributes about 12% and Mexico about 6%. Automation adoption exceeds 75% in large facilities, while approximately 58% of facilities operate high-speed encapsulation systems. Pharmaceutical applications represent about 54% of equipment usage in the region, with nutraceuticals contributing approximately 46%.

Europe

Europe represents approximately 22% of the Softgel Manufacturing Machine market, supported by pharmaceutical manufacturing, nutraceuticals, advanced machinery, contract manufacturing, and stringent quality requirements. Germany, France, and the United Kingdom collectively account for approximately 68% of regional demand. Around 61% of European manufacturers utilize advanced drying systems, while integrated automation and validation features increasingly influence purchasing decisions.

Asia-Pacific

Asia-Pacific represents the largest regional segment with approximately 38% market share. China, Japan, South Korea, India, and other Asian manufacturing centers support demand through pharmaceutical production, nutraceutical manufacturing, contract manufacturing, and machinery exports. Approximately 41% of broader softgel manufacturing equipment production is concentrated in Asia-Pacific, while China has experienced strong expansion in domestic equipment production. The region is also a major center for specialized softgel machinery manufacturing.

Middle East & Africa

Middle East & Africa accounts for approximately 6% of the Softgel Manufacturing Machine market, with demand supported by pharmaceutical manufacturing, nutraceutical production, dietary supplements, and healthcare investment. Approximately 42% of regional equipment demand is connected to pharmaceutical applications, while supplement manufacturing is expanding in selected markets. Saudi Arabia, the United Arab Emirates, South Africa, and Turkey represent important demand centers.

LIST OF KEY Softgel Manufacturing Machine Market COMPANIES PROFILED

Investment Analysis and Opportunities

Investment opportunities in the Softgel Manufacturing Machine market are expanding as pharmaceutical companies, nutraceutical manufacturers, and contract manufacturing organizations increase production capacity. Approximately 61% of new installations are fully automated, creating a strong replacement and modernization opportunity for suppliers offering servo-driven machines, automated filling systems, recipe management, electronic monitoring, and integrated quality controls. Approximately 42% of equipment purchases are associated with contract manufacturing organizations, highlighting the importance of scalable equipment capable of supporting multiple customers and formulations.

The pharmaceutical sector remains the most attractive investment area because it accounts for approximately 54% of broader softgel manufacturing equipment demand. Drug manufacturers increasingly require equipment capable of handling complex formulations while maintaining consistent fill weight, capsule dimensions, shell thickness, and sealing. Investment in high-speed machines, automated inspection, drying systems, and validated process controls can help manufacturers increase capacity without proportionally increasing manual labor.

Nutraceuticals provide another major opportunity. Health supplements represent approximately 34% of broader equipment demand, supported by vitamins, minerals, botanical extracts, omega formulations, and wellness products. Supplement producers often require flexible machinery capable of producing different capsule shapes, sizes, colors, and formulations. Equipment with rapid tooling changes and touchscreen recipe storage can therefore provide a strong competitive advantage.

NEW PRODUCTS Development

New product development in the Softgel Manufacturing Machine market is increasingly centered on servo-driven operation, automated gelatin-ribbon thickness control, precision filling, high-speed die rolls, digital recipe management, automated alignment, and integrated drying. Approximately 61% of new installations are fully automated, demonstrating the industry's shift from mechanically controlled systems toward digitally managed production lines. Manufacturers are also focusing on reducing manual intervention while maintaining consistent capsule quality.

Changsung's servo-based softgel systems demonstrate several of these developments. Its 880R system operates at approximately 6 RPM and uses servo-driven die-roll and filling processes, while its 770R machine operates at approximately 5 RPM and includes touchscreen adjustment of filling volume and automatic gelatin-thickness control. The company's R&D machine operates at approximately 3 RPM and is designed for both conventional and vegetable softgel production.

SKY Softgel & Pack has emphasized high-capacity encapsulation and integrated automation. Its SV-5000 and SV-3000 systems use large die-roll configurations and incorporate automatic zero-point setting, filling-weight adjustment, injection-timing control, automatic thickness control, and recipe-saving functions. The company also promotes turnkey production and packaging systems, reflecting a market shift toward complete automated softgel production lines rather than standalone encapsulation machines.

Recent Developments by Manufacturers in Softgel Manufacturing Machine Market

• 2024 - SKY Softgel & Pack expanded automated encapsulation and packaging capabilities: The company showcased systems incorporating automatic zero-point setting, filling-weight adjustment, injection-timing adjustment, automatic thickness control, recipe storage, and turnkey encapsulation-to-packaging integration.
• 2024 - Changsung participated in Korea Pack 2024: The company presented softgel production and packaging capabilities, emphasizing integrated manufacturing and compliance with international certification standards. The exhibition information highlighted turnkey solutions spanning softgel capsule production through bottle packaging.
• 2024 - SKY Softgel equipment entered international trade flows: Trade records document shipments of new SS-300T soft capsule filling machines from South Korea to Vietnam in November 2024, demonstrating continuing cross-border equipment deployment.
• 2024 - New high-speed softgel machine development was reported: Industry reporting identified the SG-180 system as a high-speed encapsulation machine designed for production of up to approximately 180,000 capsules per hour, reflecting the industry's focus on high-throughput manufacturing.
• 2025 - Softgel equipment research increasingly emphasized advanced automation: Current industry assessments identify higher RPM capacity, real-time monitoring, integrated drying and inspection, energy-efficient operation, and automated production as major product-development priorities for softgel machinery.

REPORT COVERAGE

The Softgel Manufacturing Machine market report covers market size, growth dynamics, technology trends, segmentation, regional outlook, competitive positioning, investment opportunities, restraints, challenges, product development, and recent manufacturer activities. The study focuses specifically on machinery used for softgel encapsulation and related production processes, with analysis structured around machine speed and end-use application.

The type analysis covers Below 3 RPM, 3-5 RPM, 5-7 RPM, 7-9 RPM, and Others. Each speed category is evaluated according to production capacity, operating requirements, automation level, application suitability, and technological development. Lower-speed machines are associated with R&D and specialty production, while higher-speed systems are increasingly used in large pharmaceutical and nutraceutical facilities. The analysis also evaluates the importance of servo drives, automated fill-weight control, gelatin-ribbon thickness management, digital recipes, and machine synchronization.

The application analysis covers Pharmaceutical and Health Supplements. Pharmaceutical production remains the leading application because softgel dosage forms are widely used for lipid-based formulations and other products requiring specialized encapsulation. Health supplements represent another major demand source, supported by vitamins, minerals, botanical extracts, omega formulations, and nutraceutical products. Approximately 54% of broader equipment demand is associated with pharmaceuticals, while nutraceuticals contribute approximately 34%.